Crossmark

Towards sustainable pharmaceutical QC: micellar-UPLC strategy for concomitant analysis of a cardiovascular polypill with aniline and salicylic acid impurities

Crossref DOI link: https://doi.org/10.1038/s41598-025-27968-w

Published Online: 2026-01-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohamed, Ahmed R.

Nour, Israa M.

Badrawy, Mohamed

Darweish, Eman
Funding

Funding for this research was provided by:

Egyptian Russian University
License Information

Text and Data Mining valid from 2026-01-22

Version of Record valid from 2026-01-23
More Information

Article History

Received: 2 July 2025

Accepted: 6 November 2025

First Online: 22 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below